Friday 6 November 2026 Export ARQT’s income statement to Excel — free account

Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $376.1 million, up 91.3% from fiscal 2024.

Revenue: +45.1%
EPS: +12.0%
Free cash flow: +1,171.9%
Total debt: +0.83%

Quarter to September 2026, against a year earlier

25.55 1.45 −5.37%

Follow ARQT

Alert me

Market cap: $3.4B
P/E: 112×
Fwd P/E: 81.2×
Dividend yield: —
F-score: 4/9
Altman Z: 6.98
Beneish M: −1.52
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	4	6	7	7
ROE Full definition →		(9.30%)	(1.43%)	15.86%	14.88%
ROA Full definition →		(4.13%)	(0.59%)	6.78%	6.68%
ROIC Full definition →		(9.91%)	2.69%	23.62%	23.48%
Return on Tangible Assets Full definition →		(5.71%)	(0.86%)	9.25%	9.01%
Average Days of Receivables Full definition →		141.92	126.79	122.06	122.90
Free Cash Flow per Share Full definition →		(0.17)	0.21	0.30	0.46
Free Cash Flow Full definition →		(21.31)	26.99	39.07	59.71
Capital Expenditures Full definition →		(15.69)	—	(0.24)	(0.25)
Other line items
Cash ROIC Full definition →		(4.10%)	5.16%	6.87%	9.74%
Accounts Receivable Turnover Full definition →		3.43	3.62	3.54	3.55
Accounts Payable Turnover Full definition →		2.74	1.76	3.79	6.35
Inventory Turnover Full definition →		1.98	1.39	1.49	1.32
Average Days of Payables Full definition →		124.61	177.38	58.65	67.86
Days of Inventory on Hand Full definition →		225.14	362.50	345.31	371.49
Tax Rate Full definition →		0.08	0.71	(0.03)	(0.03)
Research and Development Expense of Revenue Full definition →		20.49%	21.69%	19.62%	18.45%
Selling, General and Administrative Expense of Revenue Full definition →		73.01%	68.48%	64.14%	65.82%
Share Based Compensation of Revenue Full definition →		10.73%	9.93%	9.39%	9.02%
Interest Coverage Full definition →		(1.01)	0.24	2.47	2.56
Operating CF/Net income Full definition →		0.35	(11.36)	1.38	2.00
Depreciation/Fixed assets Full definition →		2.47	0.80	1.50	2.12
Capex/Depreciation Full definition →		(6.10)	0.00	(0.18)	(0.15)
Revenue per Share Full definition →		2.96	3.21	3.55	3.88
Operating CF per Share Full definition →		(0.04)	0.21	0.30	0.46
Capex per Share Full definition →		(0.12)	0.00	0.00	0.00
Capex to Sales Full definition →		0.04	0.00	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly